Hove, Belgium

Steven Anna Hostyn

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Steven Anna Hostyn in Cancer Treatment

Introduction

Steven Anna Hostyn, an accomplished inventor based in Hove, Belgium, has made significant contributions to the field of pharmaceutical innovations. With a total of four patents under his name, he has demonstrated a commitment to advancing medical treatments, particularly in oncology.

Latest Patents

Hostyn's most recent innovations include two notable patents focused on new compounds aimed at treating cancer. The first patent, titled "Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment of cancer," outlines the development of new quinoline, pyridopyrazine, naphthyridine, and quinazolinone derivative compounds. These compounds are associated with pharmaceutical compositions and processes for their preparation, highlighting their potential use in combating diseases, including cancer.

The second patent, simply referred to as "Compounds," also emphasizes the discovery of new quinoxaline, quinoline, and quinazolinone derivative compounds. Similar to his previous work, this patent includes descriptions of pharmaceutical formulations and their applications in the treatment of cancerous diseases, reflecting Hostyn's focus on effective medical solutions.

Career Highlights

Throughout his career, Hostyn has worked with leading companies in the pharmaceutical sector, including Astex Therapeutics Limited and Janssen Pharmaceutica NV. His experiences at these esteemed organizations have undoubtedly shaped his innovative spirit and expertise in drug development.

Collaborations

In the realm of collaboration, Hostyn has had the privilege of working alongside notable professionals such as Wim Vermeulen and Russell Mark Jones. These partnerships have likely facilitated the exchange of ideas and insights that contribute to his ongoing research and development efforts.

Conclusion

In summary, Steven Anna Hostyn has carved a niche for himself in the pharmaceutical industry with his innovative patents aimed at cancer treatment. His dedication and ingenuity are reflected in his work, promising advancements that could significantly impact patient care and therapeutic options in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…